• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-34a 通过 Wnt 通路影响前列腺癌细胞 PC3 的 G2 期阻滞并抑制细胞生长和迁移。

MiR-34a affects G2 arrest in prostate cancer PC3 cells via Wnt pathway and inhibits cell growth and migration.

机构信息

Department of Urinary Surgery (I), The Second Affiliated Hospital of Qiqihar Medical University, Qiqihar. P.R. China.

出版信息

Eur Rev Med Pharmacol Sci. 2020 Aug;24(16):8349-8358. doi: 10.26355/eurrev_202008_22631.

DOI:10.26355/eurrev_202008_22631
PMID:32894541
Abstract

OBJECTIVE

To investigate the effect and mechanism of miRNA-34a overexpression on proliferation and migration of PC3 prostate cancer cells.

PATIENTS AND METHODS

Benign prostatic hyperplasia tissue (30 cases), prostate cancer tissue (30 cases), and prostate paracancerous tissue (30 cases) were collected. Levels of miRNA-34a in these fresh tissues were measured by fluorescence quantitative PCR. PC3 cells were divided into non-loaded group and overexpression group. Cells in the non-loaded group were transfected with non-loaded plasmid. Cells in the overexpression group were transfected with miRNA-34a plasmid, and the miRNA-34a level was determined by fluorescence quantitative PCR to confirm the overexpression. Cell proliferation was analyzed by CCK-8 assay. Cell migration rate was measured by cell scratch assay. Flow cytometry was used to detect apoptosis and analyze cell cycle. Western blot was used to measure the expression levels of β-catenin, E-cadherin and Vimentin.

RESULTS

The expression level of miRNA-34a in prostate cancer tissue was significantly lower than that in prostate paracancerous tissue. Dual-Luciferase reporter gene assay was used to analyze the transcriptional activity of Wnt1 gene. The proliferation and migration of PC3 cells were significantly decreased after overexpression of miRNA-34a, and the differences were statistically significant compared with those in the non-loaded group (p<0.05). Flow cytometry analysis showed that in the overexpression group, the apoptotic rate, as well as the proportion of cells in the G2 phase, was significantly higher than that in the non-loaded group (p<0.05). The β-catenin level in the nucleus of PC3 cells was significantly reduced after overexpression of miRNA-34a. The total protein levels of β-catenin and Vimentin were significantly decreased, whereas the level of E-cadherin in the overexpression group was apparently increased, compared with that in the non-loaded group. The Dual-Luciferase reporter gene showed a decrease in the relative fluorescence intensity of Wnt1 after overexpression of miR-34a (p<0.05).

CONCLUSIONS

Overexpression of miRNA-34a inhibits Wnt/β-catenin pathway by regulating the transcriptional activity of Wnt1, thereby regulating the proliferation and migration of PC3 cells and promoting apoptosis.

摘要

目的

研究 miRNA-34a 过表达对 PC3 前列腺癌细胞增殖和迁移的影响及其机制。

患者与方法

收集 30 例良性前列腺增生组织、30 例前列腺癌组织和 30 例前列腺癌旁组织,采用荧光定量 PCR 检测这些新鲜组织中 miRNA-34a 的水平。将 PC3 细胞分为空载组和过表达组,空载组转染空载质粒,过表达组转染 miRNA-34a 质粒,荧光定量 PCR 检测 miRNA-34a 水平以证实过表达,CCK-8 法分析细胞增殖,细胞划痕实验检测细胞迁移率,流式细胞术检测细胞凋亡并分析细胞周期,Western blot 检测β-catenin、E-cadherin 和 Vimentin 表达水平。

结果

与前列腺癌旁组织相比,前列腺癌组织中 miRNA-34a 的表达水平明显降低。双荧光素酶报告基因检测分析 Wnt1 基因的转录活性。过表达 miRNA-34a 后,PC3 细胞的增殖和迁移明显下降,与空载组相比差异有统计学意义(p<0.05)。流式细胞术分析显示,过表达组细胞的凋亡率及 G2 期细胞比例明显高于空载组(p<0.05)。过表达 miRNA-34a 后,PC3 细胞核内β-catenin 水平明显降低,β-catenin 和 Vimentin 的总蛋白水平明显降低,E-cadherin 水平明显升高,与空载组相比差异有统计学意义。双荧光素酶报告基因显示过表达 miR-34a 后 Wnt1 的相对荧光强度降低(p<0.05)。

结论

miRNA-34a 通过调控 Wnt1 的转录活性抑制 Wnt/β-catenin 通路,从而调控 PC3 细胞的增殖和迁移,促进细胞凋亡。

相似文献

1
MiR-34a affects G2 arrest in prostate cancer PC3 cells via Wnt pathway and inhibits cell growth and migration.miR-34a 通过 Wnt 通路影响前列腺癌细胞 PC3 的 G2 期阻滞并抑制细胞生长和迁移。
Eur Rev Med Pharmacol Sci. 2020 Aug;24(16):8349-8358. doi: 10.26355/eurrev_202008_22631.
2
TUG1 knockdown inhibits the tumorigenesis and progression of prostate cancer by regulating microRNA-496/Wnt/β-catenin pathway.TUG1 敲低通过调控 microRNA-496/Wnt/β-catenin 通路抑制前列腺癌的发生发展。
Anticancer Drugs. 2020 Jul;31(6):592-600. doi: 10.1097/CAD.0000000000000882.
3
MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway.微小RNA-34a通过靶向Wnt/β-连环蛋白信号通路中的Wnt1抑制乳腺癌的增殖和进展。
Am J Med Sci. 2016 Aug;352(2):191-9. doi: 10.1016/j.amjms.2016.05.002. Epub 2016 May 7.
4
[LncRNA RPL22P1-201 affects prostate cancer cell proliferation, cell cycle, and sensitivity to docetaxel by regulating miR-216b-5p expression].[长链非编码RNA RPL22P1-201通过调控miR-216b-5p表达影响前列腺癌细胞增殖、细胞周期及对多西他赛的敏感性]
Zhonghua Nan Ke Xue. 2023 Oct;29(10):881-887.
5
LncRNA625 modulates prostate cancer cells proliferation and apoptosis through regulating the Wnt/β-catenin pathway by targeting miR-432.LncRNA625 通过靶向 miR-432 调控 Wnt/β-catenin 通路调节前列腺癌细胞的增殖和凋亡。
Eur Rev Med Pharmacol Sci. 2017 Jun;21(11):2586-2595.
6
WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway.WNT1 是 miR-34a 的一个靶标,通过 WNT/β-catenin 通路诱导 E-P 钙黏附蛋白转换,促进宫颈鳞癌细胞的增殖和侵袭。
Cell Oncol (Dordr). 2020 Jun;43(3):489-503. doi: 10.1007/s13402-020-00506-8. Epub 2020 Apr 16.
7
miR-34a Inhibitor May Effectively Protect against Sevoflurane-Induced Hippocampal Apoptosis through the Wnt/β-Catenin Pathway by Targeting Wnt1.微小RNA-34a抑制剂可能通过靶向Wnt1,经Wnt/β-连环蛋白信号通路有效保护免受七氟醚诱导的海马体细胞凋亡。
Yonsei Med J. 2018 Dec;59(10):1205-1213. doi: 10.3349/ymj.2018.59.10.1205.
8
The Long Noncoding RNA NEAT1 Targets miR-34a-5p and Drives Nasopharyngeal Carcinoma Progression via Wnt/β-Catenin Signaling.长链非编码RNA NEAT1靶向miR-34a-5p并通过Wnt/β-连环蛋白信号通路驱动鼻咽癌进展。
Yonsei Med J. 2019 Apr;60(4):336-345. doi: 10.3349/ymj.2019.60.4.336.
9
miRNA-34a-5p regulates progression of neuroblastoma via modulating the Wnt/β-catenin signaling pathway by targeting SOX4.miRNA-34a-5p 通过靶向 SOX4 调控 Wnt/β-catenin 信号通路调节神经母细胞瘤的进展。
Medicine (Baltimore). 2021 May 21;100(20):e25827. doi: 10.1097/MD.0000000000025827.
10
MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.微小RNA-34a通过直接抑制JAG1/Notch1轴减轻前列腺癌细胞对紫杉醇的耐药性。
Cell Physiol Biochem. 2018;50(1):261-276. doi: 10.1159/000494004. Epub 2018 Oct 3.

引用本文的文献

1
miRNA Signatures as Predictors of Therapy Response in Castration-Resistant Prostate Cancer: Insights from Clinical Liquid Biopsies and 3D Culture Models.微小RNA特征作为去势抵抗性前列腺癌治疗反应的预测指标:来自临床液体活检和3D培养模型的见解
Genes (Basel). 2025 Feb 1;16(2):180. doi: 10.3390/genes16020180.
2
Fungal protein D1 inhibits the proliferation of A549 cells via activating the p53/miR-34a signaling pathway.真菌蛋白D1通过激活p53/miR-34a信号通路抑制A549细胞的增殖。
J Nat Med. 2025 May;79(3):477-487. doi: 10.1007/s11418-024-01869-0. Epub 2025 Feb 18.
3
MicroRNA in prostate cancer: from biogenesis to applicative potential.
微小 RNA 在前列腺癌中的作用:从生物发生到应用潜力。
BMC Urol. 2024 Nov 6;24(1):244. doi: 10.1186/s12894-024-01634-1.
4
Aloe-emodin exhibits growth-suppressive effects on androgen-independent human prostate cancer DU145 cells via inhibiting the Wnt/β-catenin signaling pathway: an and study.芦荟大黄素通过抑制Wnt/β-连环蛋白信号通路对雄激素非依赖性人前列腺癌DU145细胞具有生长抑制作用:一项体外研究。
Front Pharmacol. 2024 Jan 29;14:1325184. doi: 10.3389/fphar.2023.1325184. eCollection 2023.
5
MicroRNA-34 Family in Cancers: Role, Mechanism, and Therapeutic Potential.癌症中的MicroRNA-34家族:作用、机制及治疗潜力
Cancers (Basel). 2023 Sep 26;15(19):4723. doi: 10.3390/cancers15194723.
6
Combination of Kaempferol and Docetaxel Induces Autophagy in Prostate Cancer Cells In Vitro and In Vivo.山奈酚和多西他赛联合诱导前列腺癌细胞的自噬作用:体内外研究。
Int J Mol Sci. 2023 Sep 25;24(19):14519. doi: 10.3390/ijms241914519.
7
Unlocking the role of non-coding RNAs in prostate cancer progression: exploring the interplay with the Wnt signaling pathway.揭示非编码RNA在前列腺癌进展中的作用:探索与Wnt信号通路的相互作用。
Front Pharmacol. 2023 Sep 27;14:1269233. doi: 10.3389/fphar.2023.1269233. eCollection 2023.
8
Deciphering the Enigmatic Influence: Non-Coding RNAs Orchestrating Wnt/β-Catenin Signaling Pathway in Tumor Progression.解读神秘影响:非编码RNA在肿瘤进展中调控Wnt/β-连环蛋白信号通路
Int J Mol Sci. 2023 Sep 10;24(18):13909. doi: 10.3390/ijms241813909.
9
Effect and Mechanism of lncRNA-PCMF1/hsa-miR-137/Twist1 Axis Involved in the EMT Regulation of Prostate Cancer Cells.lncRNA-PCMF1/hsa-miR-137/Twist1 轴在调控前列腺癌细胞 EMT 中的作用及机制。
Mol Biotechnol. 2023 Dec;65(12):1991-2003. doi: 10.1007/s12033-023-00709-y. Epub 2023 Mar 12.
10
MicroRNA-34a, Prostate Cancer Stem Cells, and Therapeutic Development.微小RNA-34a、前列腺癌干细胞与治疗进展
Cancers (Basel). 2022 Sep 19;14(18):4538. doi: 10.3390/cancers14184538.